glp-1 fda approval The has approved the first pill for weight loss, a milestone in the growth of the revolutionary drugs. The drug, a once-a-day Wegovy tablet, is also approved for reducing cardiovascular The U.S. Food and Drug

They also delay aging

Guidelines recommend GLP-1 agents with proven cardiovascular benefit for patients with type 2 diabetes and atherosclerotic cardiovascular disease

If you are transitioning from a 1 mg/mL vial to a 2 mg/mL vial, you need to draw exactly half the volume to get the same dose

Rolling ensures even distribution of the active compound throughout the solution without creating bubbles that affect dose accuracy

Methods We searched PubMed, Embase, Cochrane and ClinicalTrials.gov up until 27 October 2021 for randomised controlled trials with a duration of at least 12 weeks that compared once-weekly tirzepatide 5, 10 or 15 mg with placebo or other glucose-lowering drugs in adults with type 2 diabetes irrespective of their background glucose-lowering treatment